Biotech innovator Liquidia, specializing in pulmonary therapies, reported a notable insider sale amid continued growth in its ...

PM UTC It will lose patent exclusivity within the next two years, but Merck has earned approval for a new, subcutaneous ...

High-resistance inspiratory muscle strength training, or IMST, can help strengthen your breathing muscles. Practicing it for ...

SAN FRANCISCO, April 17, 2026 /PRNewswire/ -- A securities class action lawsuit has been filed against Gossamer Bio, Inc. (NASDAQ: GOSS) and an executive, seeking to represent investors who purchased ...

Since April 2021, the S&P 500 has delivered a total return of 68.6%. But one standout stock has more than doubled the market ...

Tectonic Therapeutic is reviving relaxin biology with TX45, targeting Group 2 Pulmonary Hypertension with HFpEF. Check out ...

Cautionary Language Concerning Forward-Looking Statements ...

Finance News; GSK completes purchase of Canada's 35Pharma for USD950 million; GSK completes purchase of Canada's 35Pharma for USD950 million ...

Youngstown State University will host an evening with Dr. Rana Awdish, a nationally recognized pulmonary and critical care physician and author, 6 to 7 p.m. April 23 in the recital hall of Bliss Hall.

On Monday, the Scottish Medicines Consortium (SMC) said it had accepted five out of six newly-licensed medicines under ...

Positive airway pressure therapy is linked with reduced pulmonary arterial pressures in patients with severe obstructive sleep apnea or obesity hypoventilation syndrome.

As of April 8, 2026, sentiment around Gossamer Bio, Inc. (NASDAQ:GOSS) remains cautious, with 56% of covering analysts ...